Chemistry and regulatory in drug development

被引：0
|
作者：
Charpentier, Bonnie A. [1 ]
机构：
[1] US & Metabolex Inc, Amer Chem Soc, Board Directors, Hayward, CA 94545 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
371-CHED
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Regulatory considerations in oncologic biosimilar drug development
    Macdonald, Judith C.
    Hartman, Helen
    Jacobs, Ira A.
    MABS, 2015, 7 (04) : 653 - 661
  • [22] Impact of regulatory issues on drug development for the CNS
    Kuruma, I
    PRECLINICAL AND CLINICAL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE, CEREBROVASCULAR AND MENTAL DISORDERS, 1996, 11 : 281 - 282
  • [23] An overview of the regulatory approval process in drug development
    Chow, SC
    Pong, A
    DRUG INFORMATION JOURNAL, 1998, 32 : 1175S - 1185S
  • [24] Regulatory Framework for Drug Development in Rare Diseases
    Korth-Bradley, Joan M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 : S15 - S26
  • [25] Regulatory Trends in Drug Development in Asia Pacific
    Fengyun Vicky Han
    Karen Weiss
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 497 - 501
  • [26] Regulatory aspects of integration of pharmacogenetics into drug development
    Shah R.R.
    International Journal of Pharmaceutical Medicine, 2001, 15 (2) : 67 - 69
  • [27] Regulatory Trends in Drug Development in Asia Pacific
    Han, Fengyun
    Weiss, Karen
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (04) : 497 - 501
  • [28] Transporters in Drug Development: Scientific and Regulatory Considerations
    Zhang, Lei
    Huang, Shiew-Mei
    Reynolds, Kellie
    Madabushi, Rajanikanth
    Zineh, Issam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 793 - 796
  • [29] New regulatory framework for cancer drug development
    Jones, Paul S.
    Jones, David
    DRUG DISCOVERY TODAY, 2012, 17 (5-6) : 227 - 231
  • [30] Pharmacogenetics in drug development: Regulatory and clinical considerations
    Hall, ST
    Abbott, N
    Schmith, G
    Brazell, C
    DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 102 - 111
12345